Google
Trusted Resources: News & Events
Latest announcements and gatherings
P.O.W.E.R ECHO Project Community Health Worker (CHW) Training – 4/18/24
Cost: Free
Monthly sessions
12–1 p.m. EST
Zoom online training
The P.O.W.E.R ECHO Project Community Health Worker Training is designed to assist community health workers with resources and education, in order to strengthen their efforts in providing support services for sickle cell disease (SCD) patients. P.O.W.E.R ECHO Project uses the ECHO telecommunication model to reach community health workers by offering online training services on emerging and current topics in sickle cell disease.
The P.O.W.E.R. training for Community Health Workers (CHWs) is designed to provide CHWs working in the SCD community with further resources and educational tools to strengthen their efforts in providing supportive services for sickle cell disease patients and their families.
The P.O.W.E.R ECHO Project uses the ECHO telecommunication model to bridge CHWs from various regions in professional development sessions focused on current and emerging sickle cell disease topics through training and case study discussions.
Upcoming Session:
Thursday, April 18 | 12-1 p.m. EST
Topic: The Significance of Outreach
Monica Rockwell, Executive Director, SWGA Sickle Cell Awareness
Click here to register
+myBinderRelated Content
-
Mary Hulihan, DrPHDr. Mary Hulihan is the Health Scientist...
-
Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency DepartmentOBJECTIVE: The aim of this study was to ...
-
Acute Vaso-Occlusive pain associated with the onset of menstruation is distinct from dysmenorrhea in sickle cell dis...Acute vaso-occlusive pain episodes are t...
-
Michelle Matthews, MDDr. Michelle Allyson Matthews is a medic...
-
Gene Therapy & Clinical Trials Webinarhttps://www.youtube.com/watch?v=yYexIUgH...
-
Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now availab...Medunik USA, a company dedicated to impr...
-
FDA Clears Graphite Bio to Begin Trial for Gene Therapy in Sickle Cell DiseaseIn response to Graphite Bio’s investig...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.